434 related articles for article (PubMed ID: 33466227)
21. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.
Iversen K; Kristensen JH; Hasselbalch RB; Pries-Heje M; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Sten C; Engel Møller ME; Benfield T; Ullum H; Jørgensen CS; Erikstrup C; Ostrowski SR; Nielsen SD; Bundgaard H
Clin Microbiol Infect; 2022 May; 28(5):710-717. PubMed ID: 34543759
[TBL] [Abstract][Full Text] [Related]
22. Serology suggests adequate safety measures to protect healthcare workers from COVID-19 in Shiga Prefecture, Japan.
Chano T; Morita SY; Suzuki T; Yamashita T; Fujimura H; Yuri T; Menju M; Tanaka M; Kakuno F
PLoS One; 2022; 17(6):e0270334. PubMed ID: 35749426
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.
Schubl SD; Figueroa C; Palma AM; de Assis RR; Jain A; Nakajima R; Jasinskas A; Brabender D; Hosseinian S; Naaseh A; Hernandez Dominguez O; Runge A; Skochko S; Chinn J; Kelsey AJ; Lai KT; Zhao W; Horvath P; Tifrea D; Grigorian A; Gonzales A; Adelsohn S; Zaldivar F; Edwards R; Amin AN; Stamos MJ; Barie PS; Felgner PL; Khan S
BMC Infect Dis; 2023 May; 23(1):330. PubMed ID: 37194021
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
[TBL] [Abstract][Full Text] [Related]
25. Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort Study.
Wilkins JT; Hirschhorn LR; Gray EL; Wallia A; Carnethon M; Zembower TR; Ho J; DeYoung BJ; Zhu A; Rasmussen-Torvik LJ; Taiwo B; Evans CT
Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1207-1215. PubMed ID: 34369331
[TBL] [Abstract][Full Text] [Related]
26. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection among health care workers in Nasarawa State, Nigeria: implications for infection prevention and control measures.
Akyala AI; Awayimbo JR; Elayo MI; Olugbade OT; Akabe EA; Akinyoade A
Pan Afr Med J; 2020; 37(Suppl 1):21. PubMed ID: 33456645
[TBL] [Abstract][Full Text] [Related]
27. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
[TBL] [Abstract][Full Text] [Related]
28. Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
Ferreira VH; Chruscinski A; Kulasingam V; Pugh TJ; Dus T; Wouters B; Oza A; Ierullo M; Ku T; Majchrzak-Kita B; Humar ST; Bahinskaya I; Pinzon N; Zhang J; Heisler LE; Krzyzanowski PM; Lam B; Lungu IM; Manase D; Pace KM; Mashouri P; Brudno M; Garrels M; Mazzulli T; Cybulsky M; Humar A; Kumar D
PLoS One; 2021; 16(2):e0247258. PubMed ID: 33592074
[TBL] [Abstract][Full Text] [Related]
29. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo.
Fukuda H; Seyama K; Ito K; Ai T; Nojiri S; Hori S; Wakita M; Saito K; Shida Y; Nagura R; Hasegawa M; Kanemoto C; Tokuhara M; Okajima K; Yoshikawa Y; Katsuta N; Yamamoto T; Idei M; Horiuchi Y; Yamatani K; Misawa S; Naito T; Miida T; Sato H; Hattori N; Tabe Y; Takahashi K
Sci Rep; 2021 Apr; 11(1):8380. PubMed ID: 33863960
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
[TBL] [Abstract][Full Text] [Related]
32. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
[TBL] [Abstract][Full Text] [Related]
33. Source and symptoms of COVID-19 among hospital workers in Milan.
Mandić-Rajčević S; Masci F; Crespi E; Franchetti S; Longo A; Bollina I; Velocci S; Amorosi A; Baldelli R; Boselli L; Negroni L; Zà A; Orfeo NV; Ortisi G; Centanni S; Colosio C
Occup Med (Lond); 2020 Dec; 70(9):672-679. PubMed ID: 33269398
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 Incidence, signs and symptoms and main risk factors for COVID-19 infection in Health Care Workers: A hospital-wide survey in Salvador, Brazil.
Montaño-Castellón I; Lins-Kusterer L; Luz E; Pedroso C; Paz M; Brites C
Braz J Infect Dis; 2022; 26(4):102387. PubMed ID: 35905929
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
Taher WT; Bawazir AA; Sallam TA; Alsurimi K
BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
Chasinga TB; Cikwanine JB; Kribi S; Yoyu JT; Hofmann N; Grossegesse M; Nitsche A; Tomczyk S; Vietor AC; Leendertz FH; Eckmanns T; Kusinza AB; Munguakonkwa E; Kalk A; Raha M; Kambale NS; Ayagirwe RB; Schubert G; Mukwege D
BMJ Open; 2024 Jan; 14(1):e072212. PubMed ID: 38176860
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
[TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.
Rusakaniko S; Sibanda EN; Mduluza T; Tagwireyi P; Dhlamini Z; Ndhlovu CE; Chandiwana P; Chiwambutsa S; Lim RM; Scott F; Sibanda LM; Mutapi F
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009254. PubMed ID: 33788840
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.
Santosh CS; Tukaram DP; Maharudra K; Balkrishna A; Chinmay G; Aniket I; Kinge K; Nilam J
J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
